-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
BioXcel Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2017 to 2023.
- BioXcel Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $1.87M, a 53.5% decline year-over-year.
- BioXcel Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $9.95M, a 49.1% decline year-over-year.
- BioXcel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $18.6M, a 7.37% increase from 2022.
- BioXcel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $17.3M, a 10.9% decline from 2021.
- BioXcel Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $19.5M, a 33.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)